Allogene Therapeutics Presents Preclinical Data on Next Generation Cloak™ and Dagger™ Technologies at the Society for Immunotherapy of Cancer Annual MeetingGlobeNewsWire • 11/03/23
Allogene Therapeutics Presents Preclinical Data on a Novel Allogeneic CAR T Product Candidate Targeting Claudin18.2 at the Society for Immunotherapy of Cancer Annual MeetingGlobeNewsWire • 11/03/23
Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business UpdateGlobeNewsWire • 11/02/23
Allogene Therapeutics Announces Participation in November Investor ConferencesGlobeNewsWire • 10/30/23
Allogene Therapeutics to Report Third Quarter 2023 Financial Results on November 2, 2023GlobeNewsWire • 10/26/23
Allogene Therapeutics Announces Three Poster Presentations from its Next Generation AlloCAR T™ Platform at the Society for Immunotherapy of Cancer (SITC) Annual MeetingGlobeNewsWire • 09/27/23
Allogene Therapeutics (ALLO) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/02/23
Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business UpdateGlobeNewsWire • 08/02/23
Allogene Therapeutics to Report Second Quarter 2023 Financial Results on August 2, 2023GlobeNewsWire • 07/26/23
Allogene Therapeutics Provides Additional ALLO-501/501A Phase 1 Data in an Oral Presentation at the International Conference on Malignant Lymphoma (ICML) LuganoGlobeNewsWire • 06/15/23
Allogene Therapeutics Announces Oral Presentation of Phase 1 Data on ALLO-501/501A in Large B Cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) LuganoGlobeNewsWire • 06/09/23
Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewsWire • 06/03/23
Wall Street Analysts See a 210.24% Upside in Allogene Therapeutics (ALLO): Can the Stock Really Move This High?Zacks Investment Research • 05/26/23
Allogene Therapeutics Announces Participation in Three Upcoming Investor ConferencesGlobeNewsWire • 05/24/23